About
Small molecules that can modulate protein interactions found in disease states
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
692
By Phase
PHASE2: 4PHASE1: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 6WITHDRAWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05185089Lead Sponsor
Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
PHASE2Completed
80 participants
Started: Aug 1, 2022 · Completed: Jun 19, 2024
NCT04387981Lead Sponsor
Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects
PHASE1Completed
6 participants
Started: Jun 1, 2020 · Completed: Jun 28, 2020
NCT03596762Collaborator
A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms
PHASE2Completed
199 participants
Started: Nov 20, 2018 · Completed: Nov 21, 2019
NCT03535662Lead Sponsor
A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers
PHASE1Completed
16 participants
Started: Jun 8, 2018 · Completed: Aug 9, 2018
NCT03464526Lead Sponsor
A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis
PHASE2Withdrawn
Started: May 31, 2018 · Completed: Oct 31, 2019
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...